TF
Terence Flynn Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
56
Avg Return
Past Year
Past Year
7.9%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
47.1%
Neutral
52.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Upgraded
| $516 |
11%
upside
| 2 | +6.9% |
0
%
| 3 Dec ‘25 15 hours ago |
|
|
|
Buy
Maintained
| $120 |
17%
upside
| 2 | +0.43% |
0
%
| 2 Dec ‘25 yesterday |
|
|
|
Overweight
Maintained
| $1,290 |
25%
upside
| 3 | +7.7% |
0
%
| 24 Nov ‘25 9 days ago |
|
|
|
Overweight
Maintained
| $26 |
185%
upside
| 1 | -28% |
0
%
| 18 Nov ‘25 15 days ago |
|
|
|
Equal-Weight
Maintained
| $9 |
24%
upside
| 1 | – |
–
| 11 Nov ‘25 22 days ago |
|
|
|
Equal-Weight
Maintained
| $329 |
5%
downside
| 1 | – |
–
| 5 Nov ‘25 28 days ago |
|
|
|
Equal-Weight
Maintained
| $190 |
7%
downside
| 2 | – |
–
| 15 Oct ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $15 |
11%
downside
| 1 | – |
–
| 14 Oct ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $32 |
25%
upside
| 1 | – |
–
| 10 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $54 |
36%
upside
| 1 | +5.2% |
0
%
| 10 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $131 |
35%
upside
| 1 | -1.9% |
0
%
| 10 Oct ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $435 |
10%
downside
| 1 | – |
–
| 10 Oct ‘25 1 month ago |
|